Condition: Kidney Stone · Nephrolithiasis · Dietary Exposure · Sponsor: Insel Gruppe AG, University Hospital Bern
The aim of this randomized trial with a 2-by-2 factorial design is to test the efficacy of the SGLT2 inhibitor empagliflozin and personalized dietary counseling based on 24-hr urine collection results and dietary assessments for kidney stone recurrence prevention in patients with calcium kidney stones. Study interventions: * Empagliflozin 10 mg once daily per os for 36 months * Personalized dietary counseling for 36 months. Control interventions: * Placebo once daily per os for 36 months * Generic dietary counseling for 36 months.
This description comes directly from the study's public registry record.
Daniel G Fuster, Prof MD · +41 31 632 31 44 · daniel.fuster@unibe.ch
Always discuss trial participation with your own doctor first.
| University Hospital Amiens-Picardie | Amiens, France | Not Yet Recruiting |
| Hôpital Tenon | Paris, France | Not Yet Recruiting |
| Hôpital Européen Georges Pompidou | Paris, France | Not Yet Recruiting |
| Charité University Medicine Berlin | Berlin, Germany | Not Yet Recruiting |
| Università della Campania "Luigi Vanvitelli" | Naples, Italy | Not Yet Recruiting |
| Verona University Hospital | Verona, Italy | Not Yet Recruiting |
| Kantonsspital Aarau | Aarau, Switzerland | Not Yet Recruiting |
| Kantonsspital Baden | Baden, Switzerland | Not Yet Recruiting |
| University Hospital Basel | Basel, Switzerland | Not Yet Recruiting |
| Inselspital Bern | Bern, Switzerland | Recruiting |
| Kantonsspital Chur | Chur, Switzerland | Not Yet Recruiting |
| Kantonsspital Fribourg | Fribourg, Switzerland | Not Yet Recruiting |
+ 9 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06653738